Global Preimplantation Genetic Testing Market Outlook 2025-2034: Trends, Innovations, And Future Outlook

The Preimplantation Genetic Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Preimplantation Genetic Testing Market Size and Projected Growth Rate?
The market size for preimplantation genetic testing has seen a swift expansion in the past few years. The market is expected to escalate from a value of $0.83 billion in 2024 to $0.92 billion in 2025, boasting a compound annual growth rate (CAGR) of 11.6%. The phenomenal growth in the historic period can be related to a rise in genetic disorders, increased understanding of genetic testing, an augmentation in prenatal testing alternatives, rising demand for tailored medicine, and a heightened emphasis on preventive healthcare.

In the forthcoming years, the preimplantation genetic testing market is set to experience a swift expansion. The market is anticipated to surge to $1.41 billion by 2029 with a compound annual growth rate (CAGR) of 11.2%. The predicted growth during this period can be credited to factors such as the escalating number of fertility clinics, an uptick in genetic counselling services, the rising instance of advanced maternal age, increased access to sophisticated genetic testing platforms, and broader applications of PGT. The forecast period is expected to witness prime trends like the uptake of cutting-edge sequencing technologies, employment of expanded genetic panels, progress in non-invasive testing methods, enhancements in embryo culture systems, and progression in genetic editing technologies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20596

What Are the Major Segments in the Preimplantation Genetic Testing Market?
The preimplantation genetic testing market covered in this report is segmented -

1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs

Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp

What Are The Driving Preimplantation Genetic Testing Market Evolution?
The upswing in the number of in vitro fertilization (IVF) procedures is envisaged to fuel the expansion of the preimplantation genetic testing market. IVF procedures entail the external fertilization of an egg with sperm to create an embryo, which is then transplanted into the uterus. Technological advancements in reproductive science, higher rates of fertility issues, and elevated public awareness are the underpinnings behind the increase in IVF procedures. This surge in in vitro fertilization (IVF) procedures is strengthening the preimplantation genetic testing market by escalating the requirement for genetic scrutiny of embryos prior to implantation. For example, the Society for Assisted Reproductive Technology, a US-based entity, reported that a total of 91,771 babies were conceived via in vitro fertilization (IVF) in 2022. Thus, the surge in IVF procedures is catalyzing the preimplantation genetic testing market.

Which Firms Dominate The Preimplantation Genetic Testing Market Segments?
Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Progyny Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd., Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC

What Trends Are Expected to Dominate the Amnion Patch Market in the Next 5 Years?
Key players in the preimplantation genetic testing market are focusing on the development of state-of-the-art next-generation sequencing (NGS) instruments, to drive improvements in speed, efficiency, and accuracy in genetic screening. This will allow for an in-depth analysis and offer parents-to-be more informed decision-making capacities. NGS tools fast-track genetic study through swift, large-scale analysis of DNA and RNA. These tools offer more nuanced insights into genetic variations and gene expression, enhancing precision and paving the way for personalized medicine. For example, in July 2023, US biotech company Thermo Fisher Scientific, rolled out the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These state-of-the-art NGS tools, designed to drive IVF and ICSI research, simplify procedures from sample processing to aneuploidy analysis with cutting-edge technology integrated into the Ion Torrent Genexus sequencer. This presents a crucial milestone in the preimplantation genetic testing market, enhancing embryo screening and increasing success rates in assisted reproductive technologies.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/preimplantation-genetic-testing-global-market-report

Which Is The Largest Region In The Preimplantation Genetic Testing Market?
North America was the largest region in the preimplantation genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Preimplantation Genetic Testing Market?
2. What is the CAGR expected in the Preimplantation Genetic Testing Market?
3. What Are the Key Innovations Transforming the Preimplantation Genetic Testing Industry?
4. Which Region Is Leading the Preimplantation Genetic Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the preimplantation genetic testing market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.